<?xml version="1.0" encoding="UTF-8"?>



<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>palproject's SharePosts</title>
    <description>Information and opinions on health from palproject at HealthCentral.com. 

 HealthCentral.com is one of the top health destinations on the Web, with more than 35 condition-specific, wellness and general health Web properties.</description>
    <link>http://www.healthcentral.com/profiles/c/45509/index</link>
    <atom:link>
      <href>http://www.healthcentral.com/profiles/c/45509/rss</href>
      <rel>self</rel>
      <type>application/xml</type>
    </atom:link>
    <language>en-us</language>
    <ttl>15</ttl>
    <image>
      <title>palproject's SharePosts</title>
      <width>120</width>
      <height>19</height>
      <url>http://www.healthcentral.com/images/hc_logo_sm.gif</url>
      <link>http://www.healthcentral.com/profiles/c/45509/index</link>
    </image>
    <item>
      <guid>http://www.healthcentral.com/migraine/c/45509/26022/dupes-sufferers</guid>
      <pubDate>Fri, 25 Apr 2008 13:53:00 -0400</pubDate>
      <dc:creator>palproject</dc:creator>
      <title>Check out this story: GSK Dupes Migraine Sufferers</title>
      <description>Hi Folks,
I'd like to share with you a story that was recently posted on the Prescription Access Litigation Blog&amp;nbsp; entitled &quot;GlaxoSmithKline sets out to dupe migraine sufferers with Treximet smoke and mirrors.&quot;
GlaxoSmithKline (NYSE:GSK) sells a popular brand-name prescription drug for migraines, Imitrex. 2007 U.S. sales of Imitrex were $1.12 billion, making it a &quot;blockbuster&quot; in drug industry parlance. A single pill of Imitrex costs about...</description>
      <link>http://www.healthcentral.com/migraine/c/45509/26022/dupes-sufferers</link>
    </item>
  </channel>
</rss>

